Vireo Growth (VREOF) Property, Plant & Equipment (Net) (2020 - 2026)
Vireo Growth (VREOF) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - | 2.55 Bn |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | 3.93 Bn |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn | 3.76 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn | 13.44 Bn |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn | 1.93 Bn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 2.44 Bn |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | 90.50 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 1.41 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 2.96 Bn |
| 10 | Vireo Growth | 487.39 Mn | 345.09 Mn | 95.30 Mn | 280.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 232.30 Mn |
| Mar 31, 2026 | 232.30 Mn |
| Dec 31, 2025 | 217.50 Mn |
| Dec 31, 2025 | 217.50 Mn |
| Sep 30, 2025 | 121.24 Mn |
| Sep 30, 2025 | 121.24 Mn |
| Jun 30, 2025 | 110.66 Mn |
| Jun 30, 2025 | 110.66 Mn |
| Mar 31, 2025 | 32.84 Mn |
| Mar 31, 2025 | 32.84 Mn |
| Dec 31, 2024 | 32.31 Mn |
| Dec 31, 2024 | 32.31 Mn |
| Sep 30, 2024 | 30.51 Mn |
| Sep 30, 2024 | 30.51 Mn |
| Jun 30, 2024 | 26.26 Mn |
| Jun 30, 2024 | 26.26 Mn |
| Mar 31, 2024 | 23.54 Mn |
| Mar 31, 2024 | 23.54 Mn |
| Dec 31, 2023 | 23.29 Mn |
| Dec 31, 2023 | 23.29 Mn |